Comprehensive Introduction to the SharkCore 22G EUS-FNB Needle

The evolution of Endoscopic Ultrasound-guided Fine Needle Biopsy (EUS-FNB) has fundamentally transformed the landscape of gastroenterology and interventional oncology. At the forefront of this technological shift is the SharkCore 22G EUS-FNB needle. Designed to overcome the limitations of traditional Fine Needle Aspiration (FNA), the SharkCore platform offers clinicians a superior tool for acquiring high-quality histological samples.

Unlike traditional needles that rely on suction or specialized fanning techniques to obtain cellular material, the SharkCore 22G is engineered for core tissue acquisition. By capturing intact tissue architecture, it allows pathologists to perform not only cytological analysis but also complex immunohistochemistry (IHC) and molecular profiling. This guide explores the technical sophistication, clinical applications, and best practices for utilizing the SharkCore 22G in modern interventional settings.

Deep-Dive: Technical Specifications and Mechanisms

The SharkCore 22G is not merely a needle; it is a precision-engineered instrument designed to maximize diagnostic yield while minimizing procedural trauma.

The Geometry of the Tip

The defining characteristic of the SharkCore needle is its proprietary "crown" tip design. This unique geometry features multiple cutting surfaces that allow for the shearing of tissue rather than just piercing it.

Biomechanics of Tissue Acquisition

The core mechanism involves a "coring" action. When the needle is advanced into the target lesion, the crown-tip design facilitates the separation of a solid tissue cylinder. This preserves the stromal architecture, which is critical for the diagnosis of pancreatic neuroendocrine tumors, autoimmune pancreatitis, and subepithelial lesions. The 22G diameter provides sufficient rigidity to navigate the endoscope’s elevator mechanism while maintaining the flexibility required for transduodenal or transgastric approaches.

Extensive Clinical Indications & Usage

The SharkCore 22G is indicated for the sampling of both solid and cystic lesions within the gastrointestinal tract and adjacent organs.

Primary Clinical Indications

1. Pancreatic Solid Masses: Distinguishing between adenocarcinoma, neuroendocrine tumors, and chronic pancreatitis.
2. Subepithelial Lesions (SELs): Characterizing GISTs (Gastrointestinal Stromal Tumors) and leiomyomas.
3. Lymphadenopathy: Diagnostic staging of malignancies via mediastinal or abdominal lymph node biopsy.
4. Liver Lesions: Targeted biopsy of focal liver masses when percutaneous approaches are contraindicated.
5. Cystic Lesions: While FNB is typically for solid masses, the 22G needle can be used to biopsy mural nodules within cystic neoplasms.

Procedural Usage Protocol

Effective use of the SharkCore 22G requires a systematic approach to ensure sample integrity:

• Access: Utilize the EUS scope to identify the target lesion. Ensure the needle is retracted into the sheath before passing through the working channel.
• Deployment: Extend the needle into the lesion under real-time ultrasound guidance.
• The "Fanning" Technique: Perform 3–5 to-and-fro strokes within the lesion. The crown-tip design makes aggressive suction less necessary compared to traditional FNA needles.
• Retrieval: Retract the needle into the sheath before withdrawing the entire device from the endoscope to prevent tissue contamination.

Maintenance and Sterilization Protocols

As a single-use medical device, the SharkCore 22G is designed for patient safety and efficiency. However, the management of the device during the procedure is paramount.

• Sterilization: The device is provided sterile and must be used immediately upon opening. It is not intended for re-sterilization.
• Handling: Avoid bending the needle or the sheath during setup, as structural deformation can impede the needle's ability to extend or retract through the endoscope’s working channel.
• Disposal: Post-procedure, the device must be treated as biohazardous waste and disposed of in accordance with institutional sharps safety protocols.

Risks, Side Effects, and Contraindications

While the SharkCore 22G is highly effective, clinicians must be aware of the procedural risks associated with EUS-guided biopsies.

Potential Risks

• Pancreatitis: Post-procedure acute pancreatitis is the most common complication, often due to repeated traversing of the pancreatic parenchyma.
• Bleeding: Hemorrhage is a risk, particularly in hypervascular lesions.
• Infection: Although rare, there is a risk of introducing bacteria into cystic lesions.
• Perforation: Inadvertent advancement of the needle beyond the target lesion can lead to injury of adjacent structures.

Contraindications

• Coagulopathy: Uncorrected coagulopathy or thrombocytopenia significantly increases the risk of hemorrhage.
• Anatomical Obstruction: Inability to safely visualize the needle path due to intervening vascular structures.

Patient Outcome Improvements

The shift toward the SharkCore 22G has yielded significant improvements in patient care pathways:

1. Reduced Need for Repeat Procedures: Because the histological yield is higher, the "non-diagnostic" rate is significantly lower, preventing the need for repeat biopsies.
2. Faster Time-to-Diagnosis: High-quality cores allow for rapid IHC, enabling oncologists to initiate targeted therapy sooner.
3. Molecular Profiling: The ability to obtain intact tissue allows for genetic sequencing, which is vital for personalized medicine in pancreatic cancer.

Frequently Asked Questions (FAQ)

1. Is suction required when using the SharkCore 22G?

Generally, no. The crown-tip design is optimized for core acquisition without the need for high-volume suction, which can often lead to blood contamination of the sample.

2. Can the SharkCore 22G be used for fine needle aspiration (FNA)?

Yes, it can function as an FNA device, but its primary design advantage is the acquisition of histology (FNB) rather than just cytology.

3. How does the 22G compare to the 25G version?

The 22G offers more rigidity and a slightly larger core sample, while the 25G is more flexible and often preferred for difficult-to-reach lesions or those requiring extreme angulation of the endoscope.

4. What is the shelf life of the SharkCore needle?

The device is marked with an expiration date on the packaging. Do not use the device if the sterile barrier is compromised or the expiration date has passed.

5. Does the needle require a stylet?

The SharkCore is typically used with a stylet to prevent tissue clogging during needle advancement into the lesion.

6. Can I use this needle for EUS-guided drainage?

No. The SharkCore 22G is strictly a biopsy device. Using it for drainage can result in device failure and is not indicated.

7. What is the most common cause of a non-diagnostic sample?

Inadequate fanning or excessive blood contamination. Ensure the needle is positioned within the solid component of the lesion.

8. Is the SharkCore compatible with all EUS endoscopes?

It is compatible with all standard EUS endoscopes with a 2.8mm or larger working channel.

9. How do I handle the tissue core after extraction?

The core should be carefully expelled onto a slide or into a fixative container (like formalin) for histological processing. Avoid crushing the tissue with forceps.

10. Are there specific training requirements for this device?

While the mechanism is intuitive, proficiency in EUS-guided tissue acquisition is a prerequisite. Simulation training is recommended for clinicians new to FNB techniques.

Conclusion

The SharkCore 22G EUS-FNB needle represents a milestone in minimally invasive diagnostics. By prioritizing the structural integrity of tissue samples, it bridges the gap between traditional cytology and formal surgical biopsy. For the interventionalist, it provides a reliable, high-yield solution that improves diagnostic accuracy and optimizes clinical workflows. As molecular diagnostics continue to become central to oncology, the role of high-quality tissue acquisition tools like the SharkCore 22G will only continue to grow in importance within the orthopedic and gastroenterological surgical suites.